Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
An open-label, multi-centre, phase Ib/II study of PI3K beta selective inhibitor GSK2636771 administered in combination with paclitaxel in patients with advanced gastric cancer having alterations in PI3K/Akt pathway
- Authors
- Jung, M.; Kim, C.; Kim, H.; Lee, C.; Lee, H.; Bae, W.; Jeung, H.; Zang, D.; Park, S.; Hwang, I.; Kim, H.; Rha, S.; Chung, H.
- Issue Date
- Jul-2021
- Publisher
- ELSEVIER
- Citation
- ANNALS OF ONCOLOGY, v.32, pp S206 - S206
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 32
- Start Page
- S206
- End Page
- S206
- ISSN
- 0923-7534
1569-8041
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.